BioCentury
ARTICLE | Financial News

Syros, SteadyMed complete private placements

April 21, 2017 10:44 PM UTC

Cancer company Syros Pharmaceuticals Inc. (NASDAQ:SYRS) and drug delivery play SteadyMed Ltd. (NASDAQ:STDY) raised a total of $65 million in private placements on Friday.

Syros raised $35 million through the sale of 2.6 million shares at $13.50. Samsara BioCapital participated, as well as additional new and existing investors. JPMorgan and Cowen were placement agents. The price is a 13% discount to Syros' close on Thursday of $15.54. Syros lost $0.64 to $14.90 on Friday...